Improving Clinical, Cognitive, and Psychosocial Dysfunctions in Patients with Schizophrenia : A Neurofeedback Randomized Control Trial

Copyright © 2021 Renata Markiewicz et al.

Détails bibliographiques
Publié dans:Neural plasticity. - 1998. - 2021(2021) vom: 01., Seite 4488664
Auteur principal: Markiewicz, Renata (Auteur)
Autres auteurs: Markiewicz-Gospodarek, Agnieszka, Dobrowolska, Beata, Łoza, Bartosz
Format: Article en ligne
Langue:English
Publié: 2021
Accès à la collection:Neural plasticity
Sujets:Journal Article Randomized Controlled Trial Brain-Derived Neurotrophic Factor BDNF protein, human 7171WSG8A2
Description
Résumé:Copyright © 2021 Renata Markiewicz et al.
Objectives: The aim of this study was to use neurofeedback (NF) training as the add-on therapy in patients with schizophrenia to improve their clinical, cognitive, and psychosocial condition. The study, thanks to the monitoring of various conditions, quantitative electroencephalogram (QEEG) and brain-derived neurotrophic factor (BDNF), was supposed to give an insight into mechanisms underlying NF training results
Methods: Forty-four male patients with schizophrenia, currently in a stable, incomplete remission, were recruited into two, 3-month rehabilitation programs, with standard rehabilitation as a control group (R) or with add-on NF training (NF). Pre- and posttherapy primary outcomes were compared: clinical (Positive and Negative Syndrome Scale (PANSS)), cognitive (Color Trails Test (CTT), d2 test), psychosocial functioning (General Self-Efficacy Scale (GSES), Beck Cognitive Insight Scale (BCIS), and Acceptance of Illness Scale (AIS)), quantitative electroencephalogram (QEEG), auditory event-related potentials (ERPs), and serum level of BDNF. Results. Both groups R and NF improved significantly in clinical ratings (Positive and Negative Syndrome Scale (PANSS)). In-between analyses unveiled some advantages of add-on NF therapy over standard rehabilitation. GSES scores improved significantly, giving the NF group of patients greater ability to cope with stressful or difficult social demands. Also, the serum-level BDNF increased significantly more in the NF group. Post hoc analyses indicated the possibility of creating a separate PANSS subsyndrome, specifically related to cognitive, psychosocial, and BDNF effects of NF therapy
Conclusions: Neurofeedback can be effectively used as the add-on therapy in schizophrenia rehabilitation programs. The method requires further research regarding its clinical specificity and understanding mechanisms of action
Description:Date Completed 20.01.2022
Date Revised 20.01.2022
published: Electronic-eCollection
Citation Status MEDLINE
ISSN:1687-5443
DOI:10.1155/2021/4488664